Our client company is a mid-sized, publicly traded pharmaceutical company with a primary focus on inflammation and immunological treatments for a variety of diseases. At present, the company seeks a person to direct their pre-clinical safety assessment program. This will include acting as the strategic lead for all toxicology programs, study design, management and contractor selection for GLP and non-GLP testing, regulatory interaction and participation as an active member of drug development project teams. At the present time, this does not include the supervision of other scientists, but is expected in the future.
The company prefers a PhD level scientist with ten or more years of related experience, to include support for IND and NDA phase regulatory filings and experience in strategic drug development approaches. DABT recognition is preferred. The position reports to the company’s VP of Pre-Clinical Development and Clinical Pharmacology and is located in the San Francisco Peninsula region. An excellent compensation package will be offered to the person hired for this role.
Search assignment #1280